178 related articles for article (PubMed ID: 17696227)
21. Comparison of esophageal acid exposure at 1 cm and 6 cm above the squamocolumnar junction using the Bravo pH monitoring system.
Pandolfino JE; Lee TJ; Schreiner MA; Zhang Q; Roth MP; Kahrilas PJ
Dis Esophagus; 2006; 19(3):177-82. PubMed ID: 16722995
[TBL] [Abstract][Full Text] [Related]
22. BRAVO esophageal pH monitoring: more cost-effective than empiric medical therapy for suspected gastroesophageal reflux.
Afaneh C; Zoghbi V; Finnerty BM; Aronova A; Kleiman D; Ciecierega T; Crawford C; Fahey TJ; Zarnegar R
Surg Endosc; 2016 Aug; 30(8):3454-60. PubMed ID: 26537906
[TBL] [Abstract][Full Text] [Related]
23. Two years' experience of using the Bravo wireless oesophageal pH monitoring system at a single UK tertiary centre.
Rao NM; Campbell DI; Rao P
Acta Paediatr; 2017 Feb; 106(2):312-315. PubMed ID: 27862298
[TBL] [Abstract][Full Text] [Related]
24. Impact of measurement of esophageal acid exposure close to the gastroesophageal junction on diagnostic accuracy and event-symptom correlation: a prospective study using wireless dual pH monitoring.
Bansal A; Wani S; Rastogi A; Rastogi K; Goyal A; Hall S; Singh V; Higbee A; Sharma P
Am J Gastroenterol; 2009 Dec; 104(12):2918-25. PubMed ID: 19755975
[TBL] [Abstract][Full Text] [Related]
25. [Outpatient monitoring of oesophageal pH with a catheter-free pH-meter (Bravo System). A Study of tolerance, safety and efficacy].
Martínez de Haro LF; Munitiz V; Ortiz A; Ruiz de Angulo D; Navarro MD; Parrilla P
Cir Esp; 2008 Oct; 84(4):201-9. PubMed ID: 18928770
[TBL] [Abstract][Full Text] [Related]
26. Tolerability and clinical utility of the Bravo pH capsule in children.
Lacy BE; Edwards S; Paquette L; Weiss J; Kelley ML; Ornvold K
J Clin Gastroenterol; 2009 Jul; 43(6):514-9. PubMed ID: 19349903
[TBL] [Abstract][Full Text] [Related]
27. Sedation and Afternoon Placement of the 48-Hour Wireless Ambulatory pH Capsule Results in More Reflux on the First Day.
Patel R; Chae S; Kumar A; Richter JE
J Clin Gastroenterol; 2017 Aug; 51(7):594-598. PubMed ID: 27548735
[TBL] [Abstract][Full Text] [Related]
28. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
[TBL] [Abstract][Full Text] [Related]
29. Patients with functional heartburn are more likely to report retrosternal discomfort during wireless pH monitoring.
Lee YC; Wang HP; Chiu HM; Huang SP; Tu CH; Wu MS; Lin JT
Gastrointest Endosc; 2005 Dec; 62(6):834-41. PubMed ID: 16301022
[TBL] [Abstract][Full Text] [Related]
30. Review article: oesophageal pH monitoring--technologies, interpretation and correlation with clinical outcomes.
Kahrilas PJ; Pandolfino JE
Aliment Pharmacol Ther; 2005 Dec; 22 Suppl 3():2-9. PubMed ID: 16303031
[TBL] [Abstract][Full Text] [Related]
31. [The Additional Role of Symptom-Reflux Association Analysis of Diagnosis of Gastroesophageal Reflux Disease Using Bravo Capsule pH Test].
Jung K; Park MI; Park SJ; Moon W; Kim SE; Kim JH
Korean J Gastroenterol; 2017 Oct; 70(4):169-175. PubMed ID: 29060954
[TBL] [Abstract][Full Text] [Related]
32. 24-hour ambulatory pH-metry in patients with refractory heartburn: a prospective study.
Talaie R; Forootan M; Donboli K; Dadashzadeh N; Sadeghi A; Poorsaadat S; Moghimi B; Mohammad Alizadeh AH; Zali MR
J Gastrointestin Liver Dis; 2009 Mar; 18(1):11-5. PubMed ID: 19337627
[TBL] [Abstract][Full Text] [Related]
33. Females without reflux symptoms or gastroesophageal reflux disease have less distal esophageal acid exposure than males without reflux symptoms or gastroesophageal reflux disease.
Vega KJ; Langford-Legg T; Palacio C; Watts J; Jamal MM
Dis Esophagus; 2013 Apr; 26(3):246-9. PubMed ID: 22676484
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of three different dosages of esomeprazole in the long-term management of reflux disease: a prospective, randomized study, using the wireless Bravo pH system.
Vasiliadis KV; Viazis N; Vlachogiannakos J; Sgouros SN; Stefanidis G; Archimandritis A; Karamanolis DG
Am J Gastroenterol; 2010 Feb; 105(2):308-13. PubMed ID: 19809412
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of Gastroesophageal Reflux Disease in Children on the Autism Spectrum: A Study Evaluating the Tolerance and Utility of the BRAVO Wireless pH Monitoring.
Rodriguez L; Morley-Fletcher A; Winter H; Timothy B
J Pediatr Gastroenterol Nutr; 2022 Oct; 75(4):450-454. PubMed ID: 35830732
[TBL] [Abstract][Full Text] [Related]
36. Effect of cigarette smoking on gastroesophageal reflux measured by 24-h ambulatory esophageal pH monitoring.
Kadakia SC; Kikendall JW; Maydonovitch C; Johnson LF
Am J Gastroenterol; 1995 Oct; 90(10):1785-90. PubMed ID: 7572895
[TBL] [Abstract][Full Text] [Related]
37. Reflux characteristics of 113 GERD patients with abnormal 24-h multichannel intraluminal impedance-pH tests.
Nian YY; Feng C; Jing FC; Wang XQ; Zhang J
J Zhejiang Univ Sci B; 2015 Sep; 16(9):805-10. PubMed ID: 26365123
[TBL] [Abstract][Full Text] [Related]
38. Ambulatory pH: monitoring with a wireless system.
Schneider JH; Kramer KM; Königsrainer A; Granderath FA
Surg Endosc; 2007 Nov; 21(11):2076-80. PubMed ID: 17484003
[TBL] [Abstract][Full Text] [Related]
39. Performance, tolerability, and symptoms related to prolonged pH monitoring using the Bravo system in Mexico.
Remes-Troche JM; Ibarra-Palomino J; Carmona-Sánchez RI; Valdovinos MA
Am J Gastroenterol; 2005 Nov; 100(11):2382-6. PubMed ID: 16279888
[TBL] [Abstract][Full Text] [Related]
40. [Successful esophageal pH monitoring with Bravo capsule in patients with gastroesophageal reflux disease].
Valdovinos Díaz MA; Remes Troche JM; Ruiz Aguilar JC; Schmulson MJ; Valdovinos-Andraca F
Rev Gastroenterol Mex; 2004; 69(2):62-8. PubMed ID: 15757153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
